Co-morbidity and cardio-metabolic risk factors in patients with osteoarthrosis
Aim. To study co-morbidity prevalence, as well as metabolic effects on atherosclerosis progression and cardiovascular risk, in patients with osteoarthrosis (OA).Material and methods. In total, 83 patients with confirmed OA diagnosis (American College of Rheumatology criteria). The age of participant...
Main Author: | N. A. Artemenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1789 |
Similar Items
-
Predicting of the risk of major cardiovascular events developing in patients with chronic obstructive pulmonary disease in combination with renal dysfunction
by: E. V. Bolotova, et al.
Published: (2019-06-01) -
THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS
by: D. S. Novikova, et al.
Published: (2015-12-01) -
Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01) -
Aceclofenac: therapeutic effectiveness in osteoarthrosis
by: Tatyana Alekseyevna Raskina
Published: (2010-12-01) -
The role of questionnaires for the assessment of physical activity and suboptimal health status for primary screening of cardiovascular diseases
by: V. I. Kupaev, et al.
Published: (2019-09-01)